Blog

In Memory of Dr. Robert Brown – Vivek Subbiah

Mary McGuire/LinkedIn

Jul 8, 2025, 11:31

In Memory of Dr. Robert Brown – Vivek Subbiah

Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post on LinkedIn, by Mary McGuire, adding:

“In memory of Dr. Robert E. Brown, MD November 19, 1941 – June 15, 2025

Wow. I’m still processing the loss of Dr. Robert Brown- a brilliant pathologist and molecular biologist, and someone I learned so much from during my fellowship days in oncology.

We worked together on several translational projects, but what I’ll remember most are our conversations—me calling with questions about pathways and pathology, him always generous with his time and knowledge. His insights helped shape how I think about oncology, precision medicine and drug development to this day.

I’m grateful for all he taught me, and even more grateful to have known him.

May he rest in peace.”

Quoting Mary McGuire’s post below:

“Final farewell to my longtime mentor, colleague and friend, Dr. Robert E. “Bob” Brown, former Professor and Vice-Chair of Pathology, University of Texas McGovern Medical School, Houston.

He passed away on Father’s Day, June 15, 2025. Bob advanced the use of morphoproteomics techniques to evaluate the immunohistochemical protein expressions of target markers in tumors to guide targeted therapy – primarily for patients beyond the standard of care. He was always open to new ideas, and supported my quest to develop “biomedical analytics” pathway analysis that augmented his observed networks. Bob, you’re greatly missed.”

More posts featuring Vivek Subbiah on OncoDaily.